Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Virol Methods ; 147(1): 136-42, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17913249

ABSTRACT

Two real-time RT-PCR kits, developed by LSI (TaqVet CSF) and ADIAGENE (Adiavet CSF), obtained an agreement to be commercialised in France, subject to conditions, defined by the French Classical Swine Fever (CSF) National Reference Laboratory. The producers were asked to introduce an internal control to check the RNA extraction efficacy. The different criteria assessed were sensitivity, "pestivirus specificity", reproducibility and ease of handling, using 189 different samples. These samples were either CSFV inactivated strains or blood/serum/organs collected from CSFV experimentally infected pigs or naturally infected wild boars. The reproducibility of the assays was confirmed by the analysis of a batch-to-batch panel control that was used for inter-laboratory tests involving nine laboratories. The two kits were also tested for the use in mass diagnostics and the results proved the kits to be suited using pools of blood, serum and tonsils. Moreover, a field evaluation, carried out on spleen samples collected from the CSF surveillance of wild boars in an area known to be infected and from domestic pigs at a slaughterhouse, confirmed the high sensitivity and specificity of the two kits. This step-by-step evaluation procedure confirmed that the two commercial CSF real-time RT-PCR kits have a higher predictive value than the current diagnostic standard, Virus Isolation.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/diagnosis , Reverse Transcriptase Polymerase Chain Reaction/methods , Animals , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , Reproducibility of Results , Sensitivity and Specificity , Swine
2.
Rev Sci Tech ; 22(3): 1077-85, 2003 Dec.
Article in English | MEDLINE | ID: mdl-15005564

ABSTRACT

Two enzyme-linked immunosorbent assay (ELISA) kits were evaluated for detection of porcine reproductive and respiratory syndrome (PRRS) antibodies in pooled sera and filter discs (FDs). Elution and incubation procedures and positive thresholds for both ELISAs were determined using FDs collected from sixty non-infected pigs and five pigs with low PRRS-antibody titres. Eighty paired samples (serum/FD) from infected pigs were titrated using both ELISAs. The authors thus showed that five sera or five FDs could be pooled in one test without significant loss of sensitivity. Compared to individual sera, method sensitivity was found to be 79% and specificity 97.5%, based on data from 200 pools of FDs collected on 15 PRRS-infected farms and 120 pools collected on 71 non-infected farms. To balance loss of sensitivity, two pools of five samples from sows and one pool of five samples from finishing pigs can be tested as an alternative to seven and five single sera, respectively.


Subject(s)
Antibodies, Viral/blood , Porcine Reproductive and Respiratory Syndrome/diagnosis , Porcine respiratory and reproductive syndrome virus/immunology , Animals , Blood Specimen Collection/economics , Blood Specimen Collection/instrumentation , Blood Specimen Collection/methods , Enzyme-Linked Immunosorbent Assay/economics , Enzyme-Linked Immunosorbent Assay/veterinary , Filtration/instrumentation , Porcine Reproductive and Respiratory Syndrome/immunology , Reagent Kits, Diagnostic/economics , Reagent Kits, Diagnostic/standards , Reagent Kits, Diagnostic/veterinary , Sensitivity and Specificity , Swine
3.
J Comp Pathol ; 125(4): 292-303, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11798246

ABSTRACT

Post-weaning multisystemic wasting syndrome (PMWS) is a comparatively new disease of swine, and known to occur in France since 1996. A porcine circovirus type 2 (PCV2) is found in the lesions of affected piglets. Six piglets aged 10-13 weeks were obtained from a French PMWS-affected farm. Two showing characteristic signs of PMWS (palor, weakness and emaciation) remained in poor condition and were finally killed 6 and 9 days after their arrival in the experimental unit. Tissue homogenates from these two piglets were used to reproduce mild PMWS in specific pathogen-free (SPF) piglets. This mild PMWS consisted of pyrexia (up to 41.7 degrees C) and growth retardation (up to 30% of weight reduction compared with controls) commencing 1 week after infection and lasting 3 weeks. In seven additional trials, pyrexia, growth retardation and lesions characteristic of PMWS were consistently produced in SPF and conventional piglets. However, only four of 55 inoculated SPF piglets (7.2%) showed severe wasting disease. One died and the others had to be killed 3 to 4 weeks after inoculation. None of the inoculated animals developed antibodies to any common swine viruses or bacteria, but clear evidence of PCV2 seroconversion was obtained. Our results therefore strongly suggest that PCV2 is the primary aetiological agent of PMWS.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/isolation & purification , Disease Models, Animal , Swine Diseases/virology , Wasting Syndrome/veterinary , Animals , Circoviridae Infections/pathology , Circovirus/pathogenicity , Circovirus/physiology , Fever/veterinary , Fever/virology , Growth/physiology , Reproducibility of Results , Specific Pathogen-Free Organisms , Swine , Swine Diseases/pathology , Wasting Syndrome/etiology , Wasting Syndrome/pathology , Weaning
4.
Vet Rec ; 143(14): 385-7, 1998 Oct 03.
Article in English | MEDLINE | ID: mdl-9802195

ABSTRACT

A commercial ELISA test to detect serum anti-gE antibodies to Aujeszky's disease virus was adapted for use with muscle exudates. The muscle samples were taken from the diaphragm of pig carcasses at the slaughterhouse. Three hundred and eighty-nine pairs of samples of serum and muscle exudate were compared to determine the possibility of using muscle exudate samples in a programme to control Aujeszky's disease. Taking the serum samples as the reference, the individual sensitivity of the test was 93.2 per cent and the individual specificity was 98.3 per cent. The concentration of antibodies in the muscle exudates was on average 20 times lower than that in the serum samples.


Subject(s)
Antibodies, Viral/analysis , Herpesvirus 1, Suid/immunology , Immunoglobulin E/immunology , Pseudorabies/immunology , Swine Diseases/immunology , Animals , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/veterinary , Muscle, Skeletal/immunology , Muscle, Skeletal/virology , Pseudorabies/diagnosis , Sensitivity and Specificity , Swine
5.
Vet Immunol Immunopathol ; 61(1): 49-66, 1998 Feb 16.
Article in English | MEDLINE | ID: mdl-9613472

ABSTRACT

In three successive experiments, the immune functions of pigs persistently infected with the porcine reproductive and respiratory syndrome virus (PRRSV) have been evaluated. Non-specific immune responses were analyzed over a period of 12 weeks post-infection (PI). In addition, the capacity of PRRSV-infected pigs to develop an efficient immune response against pseudorabies virus (PRV) glycoproteins and to resist to a subsequent virulent challenge was investigated. Our results demonstrate that PRRSV produced minor effects on the immune system of pigs. The skin delayed type hypersensitivity (DTH) in response to phytohemagglutinine injection was slightly diminished one week after challenge, but was restored thereafter. However, three weeks after the infection, the total white blood cell count, and the number of CD2+, CD8+ and IgM+ cells were enhanced. The increase in numbers of CD8+ cells persisted for three consecutive weeks. Serum immunoglobulins in infected pigs also increased by week 3 PI and up to 8 weeks PI. These results show that PRRSV may have stimulating effects on the pig immune system during the phase of long-lasting infection. After immunization with PRV glycoproteins, the production of anti-PRV antibodies and skin DTH response against PRV glycoproteins were not affected. On the contrary, following a virulent PRV challenge, PRRSV-infected pigs developed a better secondary antibody response and their resistance to the infection was as effective as in control pigs. Taken together, our data do not support a systemic immunosuppressive effect of PRRSV, during the persistent phase of infection. Other mechanisms may therefore apply to explain the emergence of secondary infections in endemically infected herds.


Subject(s)
Antibodies, Viral/analysis , Porcine Reproductive and Respiratory Syndrome/immunology , Porcine respiratory and reproductive syndrome virus/immunology , Swine Diseases/immunology , Swine/immunology , Animals , Blood Cell Count/veterinary , CD2 Antigens/immunology , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Enzyme-Linked Immunosorbent Assay/veterinary , Hypersensitivity, Delayed/immunology , Immune System , Immunoglobulin M/analysis , Porcine respiratory and reproductive syndrome virus/pathogenicity , Skin/immunology , Viremia/immunology , Viremia/veterinary
6.
J Virol Methods ; 68(1): 65-80, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9395141

ABSTRACT

Transmission of porcine reproductive and respiratory syndrome virus (PRRSV) through boar semen has been demonstrated, stressing the need for a reliable semen PRRSV detection test. A diagnostic assay was developed based on amplification of the PRRSV RNA by reverse transcription and polymerase chain reaction (RT-PCR) followed by detection of the amplification products by hybridization and colorimetric assay in microwell plates. A highly reproducible and efficient method of viral RNA isolation from semen samples was set up. A combined RT-PCR procedure was performed, incorporating the use of uracil-N-glycosylase (UNG) in combination with dUTP instead of dTTP to prevent false positive results due to carry-over contamination. An RNA internal control was added during the RNA isolation procedure to detect false negative results. The colorimetric detection in microwell plates of amplification products from either PRRSV or IC RNA gave specific and objective results and was automated. A cut-off value of 1000 RNA copies or 10 TCID50 of PRRSV per ml of semen samples could be detected with this assay. Semen samples collected from experimentally-infected boars were tested with this assay and showed PRRSV excretion early after infection and for an extended period.


Subject(s)
Colorimetry/methods , Polymerase Chain Reaction/methods , Porcine respiratory and reproductive syndrome virus/isolation & purification , Semen/virology , Animals , Base Sequence , Cloning, Molecular , DNA, Viral , Evaluation Studies as Topic , Genome, Viral , Male , Molecular Sequence Data , Porcine Reproductive and Respiratory Syndrome/immunology , Porcine Reproductive and Respiratory Syndrome/virology , Porcine respiratory and reproductive syndrome virus/genetics , Porcine respiratory and reproductive syndrome virus/immunology , RNA, Viral/analysis , Reproducibility of Results , Sensitivity and Specificity , Swine , Transcription, Genetic
7.
Vet Microbiol ; 43(1): 53-63, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7716884

ABSTRACT

Four attenuated glycoprotein I deleted Aujeszky's disease virus (ADV) vaccines were compared on the basis of their ability to induce immunity in the presence of passive antibodies. The relative severity of clinical disease and amount of viral excretion following experimental challenge with virulent ADV were determined among groups of eight pigs that were unvaccinated or vaccinated with one of the four ADV vaccines. Vaccinated pigs received two vaccine doses, the first administered when passively acquired serum antibodies were still detectable at 10 weeks of age, and the second four weeks later. The experiment was divided into two trials, with vaccinated and unvaccinated control groups in each trial. Challenge with virulent ADV took place at 18 weeks of age for the first lot and 19 weeks of age for the second. Differences among the vaccines were observed with regard to clinical protection and viral excretion. Virulent virus was excreted by most of the vaccinated pigs from two to seven days after challenge. In the case of two of the vaccines, no virus excretion was detected in several of the pigs. It was confirmed that mean serum neutralizing titers at challenge are inversely associated with amount of viral excretion post-challenge. Difficulties in the standardization of vaccine trials with passive antibodies were discussed.


Subject(s)
Herpesviridae/immunology , Immunity, Maternally-Acquired/immunology , Pseudorabies/immunology , Swine Diseases/immunology , Viral Vaccines/administration & dosage , Animals , Antibodies, Viral/blood , Female , Pseudorabies/prevention & control , Pseudorabies/virology , Swine , Swine Diseases/prevention & control , Swine Diseases/virology , Vaccines, Attenuated/administration & dosage , Virus Shedding
8.
Vet Microbiol ; 31(1): 11-8, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1319623

ABSTRACT

Twelve pigs were experimentally infected with a porcine respiratory coronavirus (PRCV) by the oronasal route. Viral excretion was measured daily by two means-deep nasal swabs and air samples obtained in a cyclone sampler. Clinical signs were very slight on infected pigs. Airborne virus could be recovered from day 1 to day 6 post-infection in the cyclone sampler as well as in petri dishes placed in the same loose-box. Viral titres obtained from nasal swabs were significantly correlated with those obtained from air samples. Different collection media were compared. The most efficient media for the collection of infectious viral particles contained a protective agent such as foetal calf serum.


Subject(s)
Air Microbiology , Coronaviridae Infections/veterinary , Coronaviridae/isolation & purification , Respiratory Tract Infections/veterinary , Swine Diseases/microbiology , Animals , Antibodies, Viral/blood , Coronaviridae/immunology , Coronaviridae Infections/microbiology , Culture Media , Nasal Mucosa/microbiology , Respiratory Tract Infections/microbiology , Swine
9.
Res Vet Sci ; 52(2): 182-6, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1316629

ABSTRACT

Five groups of eight fattening pigs were vaccinated and then infected with Aujeszky's disease virus. Viral excretion was evaluated by two means: deep nasal swabbing and air sampling. It appeared that infectious airborne virus could be recovered from day 1 to day 6 after infection in the isolated units where control animals were raised. In vaccinated animals, airborne particles were also detected but the amount and duration varied in relation to their immune status at the day of virulent challenge: viral excretion was significantly lower in pigs presenting a high antibody level (1/16 to 1/64) just before infection. Results obtained with nasal swabs and with air samples were closely related. Despite its low sensitivity, the air sampling procedure could be considered as an efficient tool for reflecting infectious viral pressure in a confined atmosphere.


Subject(s)
Air Microbiology , Herpesvirus 1, Suid/isolation & purification , Pseudorabies/prevention & control , Swine Diseases/prevention & control , Viral Vaccines , Animals , Antibodies, Viral/biosynthesis , Disease Reservoirs , Evaluation Studies as Topic , Herpesvirus 1, Suid/immunology , Nasal Mucosa/microbiology , Pseudorabies/transmission , Swine , Swine Diseases/transmission , Vaccination/veterinary
10.
Arch Virol ; 123(1-2): 135-43, 1992.
Article in English | MEDLINE | ID: mdl-1312820

ABSTRACT

Eleven groups of 8 pigs were vaccinated with different vaccinal strains of pseudorabies virus deleted or not for non-essential glycoproteins (gI, gX, gp 63), then were challenged 8-9 weeks later with a virulent strain. Antibodies against the major viral glycoproteins (gII, gIII, gp 50) were titrated at the day of challenge. Excretion of the challenge strain, growth performance of the pigs, and gI antibody responses from pigs vaccinated with a gI minus strain, were monitored after the challenge. The results demonstrated a strong association between gII and gIII antibody titres before the challenge, with the amount of the challenge strain excreted and clinical protection after the challenge. Furthermore, gI antibody titres after the challenge were negatively correlated with the level of gII and gIII antibodies at the day of challenge, the virus excretion and the clinical protection after the challenge. Implications of these results for vaccination of pigs and gI antibody screening for the infection are discussed.


Subject(s)
Pseudorabies/immunology , Swine Diseases/microbiology , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/analysis , Herpesvirus 1, Suid/immunology , Herpesvirus 1, Suid/isolation & purification , Neutralization Tests , Pseudorabies/microbiology , Pseudorabies/prevention & control , Swine , Swine Diseases/immunology , Swine Diseases/prevention & control
11.
Vet Microbiol ; 29(3-4): 213-23, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1663287

ABSTRACT

Seven deleted Aujeszky's disease vaccines were compared for their ability to induce an immunity which suppresses virus excretion. For each vaccine, the levels of clinical protection and viral excretion were compared. Groups of eight pigs were vaccinated twice with attenuated deleted Aujeszky's disease vaccines (which do not express certain glycoproteins: gI, gX or gp63). Pigs were vaccinated at the beginning of the fattening period and challenge took place at the end of it when the pigs were 18-19 weeks old. Live virus vaccines were suspended in water or in an oil-in-water emulsion. The experiment was performed in three successive assays of two groups of eight pigs (except three groups for the first assay). At each assay, a control unvaccinated group of eight pigs was added to compare the effects of challenge between vaccinated and unvaccinated animals. In total, 80 pigs were involved in this experiment. All the vaccinated pigs excreted virus from 3 to 9 d after challenge. However the level of viral excretion and the duration of the period of excretion were reduced after vaccination and especially, when oil-in-water emulsion was used. There were obvious differences between vaccines. With some vaccines, when the level of viral excretion was low, the level of clinical protection was high. However, in other cases, the level of clinical protection could be good despite a higher level of viral excretion. The seroneutralizing titres were significantly and inversely related to a low level of viral excretion but not to the level of clinical protection.


Subject(s)
Herpesvirus 1, Suid/immunology , Pseudorabies/prevention & control , Vaccination/veterinary , Viral Envelope Proteins/immunology , Viral Vaccines , Animals , Herpesvirus 1, Suid/isolation & purification , Herpesvirus 1, Suid/pathogenicity , Immunization, Secondary , Injections, Intramuscular/veterinary , Nasal Mucosa/microbiology , Pseudorabies/microbiology , Swine , Viral Vaccines/administration & dosage , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...